Carmell To Sell Its Axolotl Biologix Subsidiary For 3,845,337 Shares Of Carmell Common Stock, 4,243 Shares Of Carmell Preferred Stock And Notes Payable To The Initial Sellers In The Aggregate Amount Of $8M
卡梅尔将以3,845,337股卡梅尔普通股、4,243股卡梅尔优先股和应付给初始卖方的票据出售其Axolotl Biologix子公司，总额为800万美元